Clinical Trials
47 trialsUse of a Screening Tool to Describe HIV-Related Cancer Burden and Patient Characteristics in the AMC
AIDS Malignancy Consortium
Chemotherapy and Pelvic Radiation Therapy With or Without Additional Chemotherapy in Treating Patients With High-Risk Early-Stage Cervical Cancer After Radical Hysterectomy
Radiation Therapy Oncology Group
Radiation Therapy With or Without Chemotherapy in Patients With Stage I-IIA Cervical Cancer Who Previously Underwent Surgery
GOG Foundation
SHAPE
Canadian Cancer Trials Group
Study of Carfilzomib With Irinotecan in Irinotecan-Sensitive Malignancies and Small Cell Lung Cancer Patients
Cancer Research and Biostatistics Clinical Trials Consortium
Vaccine Therapy in Preventing HPV in HIV-Positive Women in India
AIDS Malignancy Consortium
Cisplatin and Radiation Therapy With or Without Carboplatin and Paclitaxel in Patients With Locally Advanced Cervical Cancer
GOG Foundation
Cisplatin and Radiation Therapy in Treating Patients With HIV-Associated Locally Advanced Cervical Cancer
AIDS Malignancy Consortium
Standard Versus Intensity-Modulated Pelvic Radiation Therapy in Treating Patients With Endometrial or Cervical Cancer
Radiation Therapy Oncology Group
Vaccine Therapy in Treating Patients With Persistent or Recurrent Cervical Cancer
GOG Foundation
Ondansetron With/Out Dexamethasone to Prevent Vomiting in Patients Receiving Radiation to the Upper Abdomen
Canadian Cancer Trials Group
Brivanib Alaninate in Treating Patients With Persistent or Recurrent Cervical Cancer
GOG Foundation
Intensity-Modulated Radiation Therapy to the Pelvis With or Without Chemotherapy in Treating Patients With Endometrial Cancer or Cervical Cancer That Has Been Removed By Surgery
Radiation Therapy Oncology Group
Topotecan in Treating Women With Persistent or Recurrent Cervical Cancer
GOG Foundation
ABI-007 in Treating Patients With Persistent or Recurrent Cervical Cancer
GOG Foundation
Comparison of Four Combination Chemotherapy Regimens Using Cisplatin in Treating Patients With Stage IVB, Recurrent, or Persistent Cancer of the Cervix
GOG Foundation
Patient, Physician, and Nurse Factors Associated With Entry Onto Clinical Trials and Finishing Treatment in Patients With Primary or Recurrent Uterine, Endometrial, or Cervical Cancer
GOG Foundation
Docetaxel in Treating Patients With Persistent or Recurrent Cervical Cancer
GOG Foundation
Pemetrexed and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer
GOG Foundation
Celecoxib in Treating Patients With Cervical Intraepithelial Neoplasia
GOG Foundation
Capecitabine in Treating Patients With Persistent or Recurrent Cervical Cancer
GOG Foundation
Glycoprotein and Glycan in Tissue and Blood Samples of Patients With Stage IB-IVA Cervical Cancer Undergoing Surgery to Remove Pelvic and Abdominal Lymph Nodes
GOG Foundation
Radiation Therapy and Cisplatin With or Without Epoetin Alfa in Treating Patients With Cervical Cancer and Anemia
GOG Foundation
Collecting Tumor Samples From Patients With Gynecological Tumors
GOG Foundation
Pelvic Exenteration in Treating Patients With Recurrent Cervical Cancer
GOG Foundation
Cetuximab in Treating Patients With Persistent or Recurrent Cervical Cancer
GOG Foundation
Radiation Therapy and Cisplatin With or Without Amifostine for Patients With Stage IIIB or IVA Cervical Cancer
Radiation Therapy Oncology Group
Radiation Therapy and Chemotherapy in Treating Patients With Locally Advanced Cervical Cancer
GOG Foundation
Cetuximab, Cisplatin, and Radiation Therapy in Treating Patients With Stage IB, Stage II, Stage III, or Stage IVA Cervical Cancer
GOG Foundation
Radiation Therapy Plus Cisplatin and Gemcitabine in Treating Patients With Cervical Cancer
GOG Foundation
Cetuximab and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer
GOG Foundation
Pemetrexed Disodium in Treating Patients With Recurrent Cancer of the Cervix
GOG Foundation
Radiation Therapy Plus Celecoxib, Fluorouracil, and Cisplatin in Patients With Locally Advanced Cervical Cancer
Radiation Therapy Oncology Group
Surgery With or Without Chemotherapy in Treating Patients With Stage IB Cervical Cancer
GOG Foundation
Radiation Therapy With or Without Cisplatin or Fluorouracil in Treating Patients With Cancer of the Cervix
GOG Foundation
Combination Chemotherapy in Treating Patients With Recurrent or Refractory Cervical Cancer
GOG Foundation
Radiation Therapy Plus Paclitaxel and Cisplatin in Treating Patients With Cervical Cancer
GOG Foundation
Comparison of Three Chemotherapy Regimens in Treating Patients With Stage IVB, Recurrent, or Persistent Cervical Cancer
GOG Foundation
Capecitabine in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer
GOG Foundation
Vaginal Changes and Sexual Function in Patients With Cervical Cancer
GOG Foundation
Paclitaxel, Topotecan, and Cisplatin in Treating Patients With Advanced, Persistent, or Recurrent Cervical Cancer
GOG Foundation
Radiation Therapy, Paclitaxel, and Cisplatin in Treating Patients With Cancer of the Cervix
GOG Foundation
ACRIN 6651
American College of Radiology Imaging Network
Radiation Therapy With or Without Chemotherapy After Surgery in Treating Patients With Stage IB or Stage IIA Cervical Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Pelvic Drains After Radical Hysterectomy in Treating Patients With Uterine, Cervical, or Vaginal Cancer
European Organisation for Research and Treatment of Cancer - EORTC
Surgery and Vaccine Therapy in Treating Patients With Early Cervical Cancer
European Organisation for Research and Treatment of Cancer - EORTC
S9717 Tirapazamine Plus Cisplatin in Treating Patients With Metastatic, Recurrent, or Refractory Cervical Cancer
SWOG Cancer Research Network